GALTVSLRCX• 28 Days (Normalized)
GALT vs LRCX (Galectin Therapeutics Inc. vs Lam Research Corporation)
Showing Closing Date Range from Aug, 14 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GALT Performance $3.91
+13.66%
Galectin Therapeutics Inc.
Normalized Baseline0.00%
LRCX Performance $298.22
-10.27%
Lam Research Corporation
Normalized Baseline0.00%
Alpha Spread Margin GALT LEADS
+23.93%
GALT outperforming by 23.93%
GALTLRCX
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GALT LRCX
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | GALT Price | GALT Gain (%) | LRCX Price | LRCX Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $3.91 | +13.66% | $298.22 | -10.27% | +23.93% |
| Sep 10, 2026 | $3.90 | +13.37% | $298.01 | -10.34% | +23.71% |
| Sep 09, 2026 | $4.05 | +17.73% | $315.84 | -4.97% | +22.70% |
| Sep 08, 2026 | $4.14 | +20.35% | $320.42 | -3.59% | +23.94% |
| Sep 04, 2026 | $4.61 | +34.01% | $307.65 | -7.43% | +41.44% |
| Sep 03, 2026 | $4.35 | +26.45% | $292.66 | -11.94% | +38.39% |
| Sep 02, 2026 | $4.48 | +30.23% | $288.32 | -13.25% | +43.48% |
| Sep 01, 2026 | $4.17 | +21.22% | $290.20 | -12.69% | +33.91% |
| Aug 31, 2026 | $3.95 | +14.83% | $301.49 | -9.29% | +24.12% |
| Aug 28, 2026 | $4.02 | +16.86% | $301.90 | -9.16% | +26.02% |
| Aug 27, 2026 | $4.14 | +20.35% | $318.58 | -4.15% | +24.50% |
| Aug 26, 2026 | $4.15 | +20.64% | $312.88 | -5.86% | +26.50% |
| Aug 25, 2026 | $3.99 | +15.99% | $314.66 | -5.33% | +21.32% |
| Aug 24, 2026 | $3.88 | +12.79% | $310.17 | -6.68% | +19.47% |
| Aug 21, 2026 | $3.68 | +6.98% | $314.00 | -5.52% | +12.50% |
Page 1 of 2